ATR inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ATR inhibitor, covering 2025-10-02 to 2026-02-20. Get the full timeline:
Most recent: Clinical Trial Update: ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss [Phase 2]